BNP Paribas Financial Markets Buys New Stake in Doximity, Inc. (NASDAQ:DOCS)

BNP Paribas Financial Markets bought a new stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 294,009 shares of the company's stock, valued at approximately $15,697,000. BNP Paribas Financial Markets owned 0.16% of Doximity as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in DOCS. Global Retirement Partners LLC grew its position in shares of Doximity by 468.1% during the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock worth $29,000 after buying an additional 440 shares in the last quarter. UMB Bank n.a. grew its holdings in Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock worth $31,000 after acquiring an additional 235 shares in the last quarter. Larson Financial Group LLC increased its position in shares of Doximity by 49.4% in the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock valued at $40,000 after purchasing an additional 250 shares during the last quarter. Optimum Investment Advisors acquired a new stake in shares of Doximity in the 4th quarter valued at $43,000. Finally, Kapitalo Investimentos Ltda purchased a new stake in shares of Doximity during the 4th quarter worth $50,000. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Doximity Price Performance

Doximity stock opened at $59.10 on Friday. The firm's fifty day moving average price is $57.99 and its 200 day moving average price is $57.25. The company has a market capitalization of $11.03 billion, a price-to-earnings ratio of 59.10, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $85.21.

Insider Transactions at Doximity

In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $56.93, for a total transaction of $113,860.00. Following the sale, the director now directly owns 16,618 shares in the company, valued at $946,062.74. The trade was a 10.74 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Anna Bryson sold 45,000 shares of the firm's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $57.23, for a total transaction of $2,575,350.00. Following the sale, the chief financial officer now directly owns 357,165 shares of the company's stock, valued at $20,440,552.95. The trade was a 11.19 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 37.40% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have commented on DOCS shares. KeyCorp dropped their price target on shares of Doximity from $83.00 to $70.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 16th. Canaccord Genuity Group boosted their price target on shares of Doximity from $60.00 to $71.00 and gave the company a "hold" rating in a research report on Friday, February 7th. Truist Financial dropped their price objective on Doximity from $65.00 to $58.00 and set a "hold" rating on the stock in a report on Thursday, April 10th. The Goldman Sachs Group boosted their target price on Doximity from $58.00 to $80.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Finally, Raymond James restated an "outperform" rating and set a $83.00 price target (up previously from $65.00) on shares of Doximity in a research note on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $65.39.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.